Conversely, genetically predicted plasma CCL22 levels and CCL5 were positively associated with PCOS risk, indicating that CCL22 and CCL5 may serve as risk factors for the development of PCOS. The gene discussed is CCL22; the disease is polycystic ovary syndrome.